tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Jiutian Chemical Faces Arbitration Over Subsidiary Investment Loss

Story Highlights
  • Jiutian Chemical received an arbitration notice from a former subsidiary’s minority shareholder.
  • The company is addressing a RMB 2 million compensation claim for alleged investment losses.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Jiutian Chemical Faces Arbitration Over Subsidiary Investment Loss

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Jiutian Chemical Group Limited ( (SG:C8R) ) has provided an update.

Jiutian Chemical Group Limited has received a notice of arbitration from a minority shareholder of its former subsidiary, Changzhou Jiutian Xiean Chemical Co., Ltd, which is undergoing creditor’s voluntary liquidation. The arbitration, filed with the Shanghai International Arbitration Center, involves a compensation claim of RMB 2 million for alleged investment losses. The company is reviewing the claim with legal advisors and will update shareholders on any significant developments, advising caution in dealing with its securities.

More about Jiutian Chemical Group Limited

Jiutian Chemical Group Limited, incorporated in Singapore, operates in the chemical industry. The company focuses on producing and distributing chemical products, with a particular emphasis on its subsidiaries, including Changzhou Jiutian Xiean Chemical Co., Ltd.

Average Trading Volume: 1,610,606

Technical Sentiment Signal: Sell

Current Market Cap: S$49.71M

For an in-depth examination of C8R stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1